E-LIB Suche - Ergebnisse für: Rigacci L

1

A RANDOMIZED TRIAL OF OBSERVATION VERSUS RADIOTHERAPY IN PR..:

Davies, A. J. ; Zucca, E. ; Ceriani, L....
Hematological Oncology. 41 (2023) S2 - p. 48-50 , 2023

Link: https://doi.org/10.1002/..

2

P62 USE OF ANTIVIRAL FOR PAUCISINTOMATIC COVID-19 INFECTION..:

Annibali, O. ; F, Fazio ; M, Di Cecca...
HemaSphere. 7 (2023) S2 - p. 44-44 , 2023

Link: https://doi.org/10.1097/..

3

CLASSICAL HODGKIN DISEASE: PRESENCE OF TIGIT MRNA IN PERITU..:

Annibali, O. ; Tomarchio, V. ; Verri, M....
Hematological Oncology. 41 (2023) S2 - p. 640-640 , 2023

Link: https://doi.org/10.1002/..

4

P140 EFFICACY AND SAFETY OF CHEMOTHERAPY CONTAINING NON–PEG..:

Bisceglia, I ; Camilli, M ; Mistrulli, R...
European Heart Journal Supplements. 24 (2022) Supplement_C - p. , 2022

Link: https://doi.org/10.1093/..

5

C50 CARDIO–ONCO–HAEMATOLOGY IN CLINICAL PRACTICE. A "CHANGE..:

Bisceglia, I ; Mistrulli, R ; Cartoni, D...
European Heart Journal Supplements. 24 (2022) Supplement_C - p. , 2022

Link: https://doi.org/10.1093/..

6

P1208: CHARACTERISTICS AND CLINICAL OUTCOMES OF PATIENTS WI..:

Chiattone, C. ; Civallero, M. ; Fischer, T....
HemaSphere. 6 (2022) - p. 1094-1095 , 2022

Link: https://doi.org/10.1097/..

7

THE ELDERLY PROGNOSTIC INDEX (EPI) PREDICTS EARLY MORTALITY..:

Merli, F. ; Tucci, A. ; Arcari, A....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

8

A GENE EXPRESSION‐BASED SCORE TO PREDICT INTERIM PET POSITI..:

Donati, B. ; Casali, M. ; Fama, A....
Hematological Oncology. 37 (2019) S2 - p. 48-48 , 2019

Link: https://doi.org/10.1002/..

9

THE BRAF INHIBITOR VEMURAFENIB PLUS RITUXIMAB PRODUCES A HI..:

Tiacci, E. ; De Carolis, L. ; Simonetti, E....
Hematological Oncology. 37 (2019) S2 - p. 110-111 , 2019

Link: https://doi.org/10.1002/..

10

INTERIM ANALYSIS OF CENTRAL REVIEW OF END‐OF‐THERAPY PET IN..:

Guerra, L. ; Bergesio, F. ; Versari, A....
Hematological Oncology. 37 (2019) S2 - p. 393-393 , 2019

Link: https://doi.org/10.1002/..

11

OC-0502 Role of consolidation RT to bulky lesions of advanc..:

Ricardi, U. ; Levis, M. ; Evangelista, A....
Radiotherapy and Oncology. 133 (2019) - p. S258-S259 , 2019

Link: https://doi.org/10.1016/..

12

CLINICAL CHARACTERISTICS OF PATIENTS WITH NEGATIVE INTERIM‐..:

Rigacci, L. ; Puccini, B. ; Zinzani, P....
Hematological Oncology. 35 (2017) S2 - p. 38-38 , 2017

Link: https://doi.org/10.1002/..

13

REAL LIFE EXPERIENCE WITH BRENTUXIMAB VEDOTIN: THE ITALIAN ..:

Pellegrini, C. ; Pulsoni, A. ; Rigacci, L....
Hematological Oncology. 35 (2017) S2 - p. 170-171 , 2017

Link: https://doi.org/10.1002/..

14

INTERFERON‐FREE ANTIVIRAL TREATMENT IN B‐CELL LYMPHOPROLIFE..:

Frigeni, M. ; Visco, C. ; Besson, C....
Hematological Oncology. 35 (2017) S2 - p. 145-146 , 2017

Link: https://doi.org/10.1002/..

15

POD24 AND CR30 ARE PROMISING SURROGATE ENDPOINTS FOR ASSESS..:

Luminari, S. ; Marcheselli, L. ; Manni, M....
Hematological Oncology. 35 (2017) S2 - p. 228-229 , 2017

Link: https://doi.org/10.1002/..